Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Postoperative SBRT for Prostate Cancer
NCT03541850Phase 2Active, not recruiting
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Jan 2019
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial in prostate cancer (PCa), sponsored by UCLA Jonsson Comprehensive Cancer Center. Primary endpoints: Biochemical Recurrence-Free Survival at 5 years, Physician-scored toxicity at 5 years and 2 more. Started Jan 2019; status: active, not recruiting.
02
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT03541850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03541850.